Rexulti is a prescription drug approved by the Food and Drug Administration (FDA) as an adjunctive (add-on) therapy to antidepressants for treating major depressive disorder. Rexulti is also known by its drug name, Brexpiprazole.
Rexulti is an atypical antipsychotic. Rexulti is believed to work by modulating dopamine and serotonin levels in the brain.
How do I take it?
Rexulti is generally taken once daily.
Rexulti comes in tablet form.
The FDA-approved label for Rexulti lists common side effects including weight gain, feelings of restlessness, and restless movements.
Rare but serious side effects listed for Rexulti can include suicidal thoughts or behaviors in people aged 24 or younger and increased risk for death in elderly people with dementia-related psychosis.
For more details about this treatment, visit:
Rexulti - Otsuka